Publications by authors named "Bianco Assunta"

Claim this Profile
W
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review.
Assunta Bianco, Rosellina Russo, Alessandra Cicia, Sofia Marini, Matteo Lucchini

J Neuroimmunol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.
Gina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, Doriana Landi, Francesca Napoli, Assunta Bianco

Neurol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgE-mediated allergic reactions to ocrelizumab in multiple sclerosis: A retrospective cohort study.
Assunta Bianco, Arianna Aruanno, Matteo Lucchini, Alessandra Cicia, David Longhino

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great Mimic.
Flaminia Bellisario, Assunta Bianco, Francesco D'Alo', Chiara Passarelli, Rosellina Russo

Diagnostics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An early feasibility study for neurological devices: The ARCTRAN study.
Francesco Bove, Giulia Di Lazzaro, Martina Petracca, Maria Rita Lo Monaco, Diego Ricciardi, Assunta Bianco

Neurol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of cladribine-induced IgG4-associated liver injury.
Marco Biolato, Assunta Bianco, Maria Cristina Giustiniani, Massimiliano Mirabella, Maurizio Pompili

Acta Neurol Belg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study.
Caterina Lapucci, Jessica Frau, Eleonora Cocco, Giancarlo Coghe, Maria Petracca, Assunta Bianco

Mult Scler· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?
Assunta Bianco, Gabriele Di Sante, Francesca Colò, Valeria De Arcangelis, Alessandra Cicia

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome.
Domenico Plantone, Eleonora Sabatelli, Sara Locci, Mariano Marrodan, Sini M Laakso, Assunta Bianco

Eur J Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).
Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, Massimiliano Calabrese, Fioravante Capone

Neurotherapeutics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report.
Assunta Bianco, Francesca Colò, Silvia Falso, Rosellina Russo, Matteo Maria Carlà

J Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A true isolated cognitive relapse in multiple sclerosis.
Valeria Pozzilli, Alessandro Cruciani, Fioravante Capone, Francesco Motolese, Mariagrazia Rossi, Assunta Bianco

Neurol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis.
Matteo Lucchini, Valeria De Arcangelis, Geny Piro, Viviana Nociti, Assunta Bianco

Mol Neurobiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients.
Maria Tredicine, Francesco Ria, Noemi Poerio, Matteo Lucchini, Assunta Bianco

Biomaterials· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.
Alvino Bisecco, Arianna Fornasiero, Assunta Bianco, Antonio Cortese, Emanuele D'Amico

J Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre.
Matteo Lucchini, Paola Del Giacomo, Valeria De Arcangelis, Viviana Nociti, Assunta Bianco

J Pers Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.
Bisecco Alvino, Fornasiero Arianna, Bianco Assunta, Cortese Antonio, d'Amico Emanuele

J Neurol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies.
Fioravante Capone, Matteo Lucchini, Elisabetta Ferraro, Assunta Bianco, Mariagrazia Rossi

Neurotherapeutics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach.
Alessandra Cicia, Viviana Nociti, Assunta Bianco, Chiara De Fino, Vincenzo Carlomagno

Transl Neurosci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients.
Assunta Bianco, Matteo Lucchini, Rocco Totaro, Roberta Fantozzi, Giovanna De Luca

Neurotherapeutics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis.
Tommaso Nicoletti, Assunta Bianco, Matteo Lucchini, Simona Gaudino, Giovanni Frisullo

Ther Adv Neurol Disord· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.
Marco Biolato, Assunta Bianco, Matteo Lucchini, Antonio Gasbarrini, Massimiliano Mirabella

CNS Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the disease course of TNFα blockers-associated Multiple Sclerosis.
Matteo Lucchini, Guido Maria Giuffrè, Viviana Nociti, Assunta Bianco, Chiara De Fino

J Neuroimmunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report.
Matteo Lucchini, Assunta Bianco, Paola Del Giacomo, Chiara De Fino, Viviana Nociti

Mult Scler Relat Disord· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
Clara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, Roberto Bergamaschi, Assunta Bianco

J Neurol Neurosurg Psychiatry· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis